You are viewing an incomplete version of our website. Please click to reload the website as full version.

Aperçu des produits pour anti-FLT4 (FLT4) Anticorps

Full name:
anti-Fms-Related Tyrosine Kinase 4 Anticorps (FLT4)
Chez sont 209 Fms-Related Tyrosine Kinase 4 (FLT4) Anticorps de 36 de différents fournisseurs disponibles. De plus, nous expédions FLT4 Kits (45) et FLT4 Protéines (31) et beaucoup plus de produits pour cette protéine. Un total de 293 FLT4 produits sont actuellement listés.
6130401C07, AI323512, cb1059, Chy, Flk-1, Flk1, Flt-4, FLT41, Krd-1, LMPH1A, Ly73, PCL, sVEGFR-2, VEGFR-2, VEGFR-3, VEGFR2, Vegfr3

Tous anti-FLT4 Anticorps disponible

Vous arrivez à notre recherche pré-filtrée.

anti-FLT4 Anticorps mieux référencés

  1. Human Monoclonal FLT4 Primary Antibody pour WB - ABIN1882290 : Pajusola, Aprelikova, Korhonen, Kaipainen, Pertovaara, Alitalo, Alitalo: FLT4 receptor tyrosine kinase contains seven immunoglobulin-like loops and is expressed in multiple human tissues and cell lines. dans Cancer research 1992 (PubMed)
    Show all 4 references for ABIN1882290

  2. Human Polyclonal FLT4 Primary Antibody pour WB - ABIN616061 : Paone, Galli, Gabellini, Lukashev, Starace, Gorlach, De Cesaris, Ziparo, Del Bufalo, Sitkovsky, Filippini, Riccioli: Toll-like receptor 3 regulates angiogenesis and apoptosis in prostate cancer cell lines through hypoxia-inducible factor 1 alpha. dans Neoplasia (New York, N.Y.) 2010 (PubMed)
    Show all 3 references for ABIN616061

  3. Human Monoclonal FLT4 Primary Antibody pour ELISA, WB - ABIN969147 : Goodyear, Kheyfets, Garcia, Stearns: Role of the VEGFR3/VEGFD receptor axis in TGFbeta1 activation of primary prostate cell lines. dans The Prostate 2009 (PubMed)
    Show all 3 references for ABIN969147

  4. Human Polyclonal FLT4 Primary Antibody pour IHC (fro), IHC (p) - ABIN115449 : Earnshaw, Halligan, Cooke, Heck, Liu: Topoisomerase II is a structural component of mitotic chromosome scaffolds. dans The Journal of cell biology 1985 (PubMed)
    Show all 2 references for ABIN115449

  5. Human Monoclonal FLT4 Primary Antibody pour EIA, IHC (fro) - ABIN115161 : Davids, Davids, Charlton, Ng, Chong, Laubscher, Dar, Hodge, Soong, Goh: Response to a novel multitargeted tyrosine kinase inhibitor pazopanib in metastatic Merkel cell carcinoma. dans Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009 (PubMed)
    Show all 2 references for ABIN115161

  6. Human Monoclonal FLT4 Primary Antibody pour EIA, WB - ABIN115160 : Jussila, Valtola, Partanen, Salven, Heikkilä, Matikainen, Renkonen, Kaipainen, Detmar, Tschachler, Alitalo, Alitalo: Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3. dans Cancer research 1998 (PubMed)
    Show all 2 references for ABIN115160

  7. Human Polyclonal FLT4 Primary Antibody pour IF (p), IHC (p) - ABIN678578 : Wang, Zhou, Lin, Wang, Lin, Li: RhGH attenuates ischemia injury of intrahepatic bile ducts relating to liver transplantation. dans The Journal of surgical research 2011 (PubMed)
    Show all 2 references for ABIN678578

  8. Mouse (Murine) Monoclonal FLT4 Primary Antibody pour IHC (fro), IHC (p) - ABIN967368 : Kubo, Fujiwara, Jussila, Hashi, Ogawa, Shimizu, Awane, Sakai, Takabayashi, Alitalo, Yamaoka, Nishikawa: Involvement of vascular endothelial growth factor receptor-3 in maintenance of integrity of endothelial cell lining during tumor angiogenesis. dans Blood 2000 (PubMed)
    Show all 2 references for ABIN967368

  9. Human Polyclonal FLT4 Primary Antibody pour IHC (p) - ABIN115450 : Dietrich, Onderka, Bock, Kruse, Vossmeyer, Stragies, Zahn, Cursiefen: Inhibition of inflammatory lymphangiogenesis by integrin alpha5 blockade. dans The American journal of pathology 2007 (PubMed)

Plus d’anticorps contre FLT4 partenaires d’interaction

Mouse (Murine) Fms-Related Tyrosine Kinase 4 (FLT4) interaction partners

  1. administration of 0.3 IU/mL FSH (Montrer BRD2 Anticorps) during ovarian cryopreservation by vitrification can maintain ovarian survival during ovarian vitrification and increases the blood supply with avascular transplantation via upregulation of Cx43 (Montrer GJA1 Anticorps), Cx37 (Montrer GJA4 Anticorps), and VEGF (Montrer VEGFA Anticorps)/VEGFR2 (Montrer KDR Anticorps)

  2. The data provide new insights for the chaperone function of PDCL3 (Montrer PDCL3 Anticorps) in angiogenesis and the roles of hypoxia and N-terminal methionine acetylation in PDCL3 (Montrer PDCL3 Anticorps) expression and its effect on VEGFR-2 (Montrer KDR Anticorps).

  3. VEGFA (Montrer VEGFA Anticorps)-induced vascular leakage depends on signaling initiated via the VEGFR2 (Montrer KDR Anticorps) phosphosite Y949. Abolished Y949 signaling in the mutant Vegfr2 (Montrer KDR Anticorps)(Y949F/Y949F) leads to VEGFA (Montrer VEGFA Anticorps)-resistant endothelial adherens junctions.

  4. These findings together demonstrate the essential role of KDM4A (Montrer KDM4A Anticorps) and KDM4C (Montrer KDM4C Anticorps) in orchestrating mESC differentiation to endothelial cells through the activation of Flk1 (Montrer KDR Anticorps) and VE-cadherin (Montrer CDH5 Anticorps) promoters, respectively

  5. VEGFA (Montrer VEGFA Anticorps)/VEGFR2 (Montrer KDR Anticorps) signaling may be essential for podocytes in a normal state.

  6. Tnfsf15 (Montrer TNFSF15 Anticorps), a cytokine produced largely by endothelial cells, facilitates lymphangiogenesis by up-regulating Vegfr3 gene expression in LECs, contributing to the maintenance of the homeostasis of the circulatory system.

  7. Thus, (131)I-anti-VEGFR2 (Montrer KDR Anticorps) cFab (Montrer CFB Anticorps) has the potential to be used for molecularly targeted treatment of hepatocellular carcinoma overexpressing VEGFR2 (Montrer KDR Anticorps).

  8. tumors in stressed animals demonstrated markedly enhanced expression of VEGFR-2 (Montrer KDR Anticorps) and L1CAM (Montrer L1CAM Anticorps) mRNA as well as pERK (Montrer EIF2AK3 Anticorps), MMP-2 (Montrer MMP2 Anticorps) and MMP-9 (Montrer MMP9 Anticorps) protein expression.

  9. These results suggest that VEGFR2 (Montrer KDR Anticorps)-mediated Muller cell survival is required for the viability of retinal neurons in diabetes.

  10. Results showed that the VEGF-C (Montrer VEGFC Anticorps)/VEGFR-3 system underlies the protective effect of ischemic preconditioning against forebrain ischemia in the mouse hippocampus

Human Fms-Related Tyrosine Kinase 4 (FLT4) interaction partners

  1. High expression levels of VEGFR1 (Montrer FLT1 Anticorps) and VEGFR3 were associated with a higher rate of lung metastasis.

  2. Data indicate that foretinib suppresses angiogenesis and lymphangiogenesis by blocking vascular endothelial growth factor receptors

  3. Genistein suppresses FLT4 and inhibits human colorectal cancer metastasis.

  4. A Novel Missense Mutation in FLT4 Causes Autosomal Recessive Hereditary Lymphedema

  5. our findings contribute to the putative targets in which the FLT4 gene mutation was found to have a significant role in lymphatic filariasis, while FOXC2 (Montrer FOXC2 Anticorps) and FLT4 SNP interactions need to be further elucidated at a functional level.

  6. Missense mutations in VEGFR3 confirmed Milroy disease in two unrelated patients.

  7. Case Reports: novel FLT4 gene mutation in a Chinese family with Milroy disease.

  8. These findings suggest that IL-8 (Montrer IL8 Anticorps) may be a potent inducer of LECs, although this effect does not appear to involve the VEGF-C (Montrer VEGFC Anticorps)/VEGF-D (Montrer Figf Anticorps) and VEGFR-3 signaling pathway.

  9. TNFR1 (Montrer TNFRSF1A Anticorps) has a role in mediating TNF-alpha (Montrer TNF Anticorps)-induced tumour lymphangiogenesis and metastasis by modulating VEGF-C (Montrer VEGFC Anticorps)-VEGFR3 signalling

  10. The results show that VEGFR1 (Montrer FLT1 Anticorps)-VEGFR2 (Montrer KDR Anticorps) levels are more closely coupled than VEGFR1 (Montrer FLT1 Anticorps)-VEGFR3 or VEGFR2 (Montrer KDR Anticorps)-VEGFR3 in HUVEC and MEC (Montrer CCL28 Anticorps).

Zebrafish Fms-Related Tyrosine Kinase 4 (FLT4) interaction partners

  1. Experiments in mice and zebrafish demonstrate that changing levels of VEGFR3/Flt4 modulates aortic lumen diameter consistent with flow-dependent remodeling

  2. In the embryo, phenotypes driven by increased Vegfc (Montrer VEGFC Anticorps) are suppressed in the absence of Ccbe1 (Montrer CCBE1 Anticorps), and Vegfc (Montrer VEGFC Anticorps)-driven sprouting is enhanced by local Ccbe1 (Montrer CCBE1 Anticorps) overexpression. Moreover, Vegfc (Montrer VEGFC Anticorps)- and Vegfr3-dependent Erk (Montrer MAPK1 Anticorps) signaling is impaired in the absence of Ccbe1 (Montrer CCBE1 Anticorps).

  3. Flt4 plays an essential role in lymphangiogenesis [review]

  4. The parallel growth of motoneuron axons with the dorsal aorta depends on Vegfc (Montrer VEGFC Anticorps)/Vegfr3 signaling in zebrafish.

  5. Rspo1-Wnt-VegfC-Vegfr3 signaling plays a crucial role as an endothelial-autonomous permissive cue for developmental angiogenesis.

  6. flt4 signalling is suppressed by Dll4 (Montrer DLL4 Anticorps) in developing zebrafish intersegmental arteries.

FLT4 profil antigène

Antigen Summary

This gene encodes a tyrosine kinase receptor for vascular endothelial growth factors C and D. The protein is thought to be involved in lymphangiogenesis and maintenance of the lymphatic endothelium. Mutations in this gene cause hereditary lymphedema type IA.

Alternative names and synonyms associated with FLT4

  • FMS-like tyrosine kinase 4 (Flt4) anticorps
  • fms-related tyrosine kinase 4 (FLT4) anticorps
  • fms-related tyrosine kinase 4 (Flt4) anticorps
  • fms-related tyrosine kinase 4 (flt4) anticorps
  • kinase insert domain protein receptor (Kdr) anticorps
  • 6130401C07 anticorps
  • AI323512 anticorps
  • cb1059 anticorps
  • Chy anticorps
  • Flk-1 anticorps
  • Flk1 anticorps
  • Flt-4 anticorps
  • FLT41 anticorps
  • Krd-1 anticorps
  • LMPH1A anticorps
  • Ly73 anticorps
  • PCL anticorps
  • sVEGFR-2 anticorps
  • VEGFR-2 anticorps
  • VEGFR-3 anticorps
  • VEGFR2 anticorps
  • Vegfr3 anticorps

Protein level used designations for FLT4

chylous ascites , receptor protein tyrosine kinase , tyrosine-protein kinase receptor FLT4 , vascular endothelial growth factor receptor 3 , vascular endothelial growth factor receptor-3 , FLT-4 , VEGFR-3 , fms-like tyrosine kinase 4 , soluble VEGFR3 variant 1 , soluble VEGFR3 variant 2 , soluble VEGFR3 variant 3 , FMS-like tyrosine kinase 4 , tyrosine kinase VEGFR-3 , VEGFR3 , expando , receptor tyrosine kinase Flt4 , VEGF receptor-2 , fetal liver kinase 1 , kinase NYK , protein-tyrosine kinase receptor flk-1 , soluble vascular endothelial growth factor receptor 2 , vascular endothelial growth factor receptor 2 , vascular endothelial growth factor receptor- 2 , vascular endothelial growth factor receptor-2

14257 Mus musculus
2324 Homo sapiens
114110 Rattus norvegicus
338031 Bos taurus
100008829 Oryctolagus cuniculus
395742 Gallus gallus
30121 Danio rerio
16542 Mus musculus
Fournisseurs de qualité sélectionnés pour anti-FLT4 (FLT4) Anticorps
Avez-vous cherché autre chose?